Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Cellular Goods PLC (CLAI)

London
Currency in GBP
Disclaimer
0.20
-0.03(-13.04%)
Real-time Data

CLAI Price Commentary

CEO steps down and shares shoot up?
Good time to double your money
good time to add in more...
https://cellulargoods.co/learn/articles/research/white-paper-cannabinoids-for-the-prevention-of-aging-whitepaper
stay way if you're on "get rich quick" strategy. this is not for you.
This is starting to get a little worrying, December was meant to the start of the big take off.
I feel this will regain moment in the new yr when the really promotion happens, but the price is more expensive than I thought, so feel the a big customer base is missed, the first q sales will reveal this, time will tell.
so product go on sale and it goes down 🤔
The products launched are face oil, face serum, oral drops, oral spray and after shaving moisturiser.the products aren’t cheap at all, given that they start at around £44, and the most expensive product, the face serum, retails for £89. Ordinary person will struggle to afford them. Rich people very much doubt it as they have a wide range already on market. Kind of a let down
December let's see the start of the moon climb
Slowly creeping up, lets hope December is the month 🤞
This is a great rise. December month this will take off
Product launch bounce coming soon.
cant wait peter this should be epic.
I'm not sure about this stock. Going sub 6p due to no products, then likely shortages and then can't deliver so it's going to be awhile before they make money then Beckham is no longer locked in and will sell out. Thoughts?
go on my son . keep rising. I need to make my money back. December month will be a game changer.
Ethereum MAX going to sky rocket. (eMax) you here it hear first. Have a good weekend.
a IPO has just been released for PensionBee £1.55 p/s.  Only on offer to customers at the moment.  Looks interesting, something I'll be keeping an eye on.
They need to emphasise product safety more.
it's holding nice and steady now which is good to see, solid foundations is what is needed.
To the moon 😅
The most common mechanisms leading to death following synthetic cannabinoid use include behavioral risks, such as self-harm and suicide, falling from a height, and wandering into traffic; cardiovascular effects; and central nervous system depression.
There have been several deaths linked to synthetic cannabinoids. The Centers for Disease Control and Prevention (CDC) found that the number of deaths from synthetic cannabinoid use tripled between 2014 and 2015.[9][10] In 2018, the United States Food and Drug Administration warned of significant health risks from synthetic cannabinoid products that contain the rat poison brodifacoum, which is added because it is thought to extend the duration of the drugs' effects.[11] Severe illnesses and death have resulted from this contamination.[11]
Even if true, a miniscule fraction compared deaths caused by alcohol, cigarettes and recreational drugs without a doubt! Drink enough water and that will also cause death! Stop your scaremongering!
Where can I buy CBXs products?  Can't find anything online!
That's because they've yet to develop any. I would have thought they'd need a few bio-chemists to liaise with their prospective suppliers of the synthetic material in the USA. Instead they seem to have several managers and financial consultants.
I’m still waiting for my shares to show in my broker account. This is despite me purchasing via Primary Bid well in advance of the floatation date. Can I assume that I am not alone on this?
 I saw it was 13x oversubscribed. I was going to buy some, only to sell on the first day of listing, but the offer closed early and I missed it.
was scaled back. I tried to buy £16k. Got £900ish worth. Which was fair enough.
 so, no one bought the minimum of 100 ?
From the Path Finder Document: -   16.) Intellectual property The Company is not dependent on  [= does not have] any patents or licences, industrial, commercial or financial contracts, or new manufacturing processes, where such are of fundamental importance to the Company’s business or profitability. 17.) Premises The Company does not own any premises or hold any leasehold interests in any properties. 18.) Employees The Company currently employs five people including the executive directors and currently engages four nonexecutive directors and six consultants.
Down she goes, just like the Titanic!
it's moving down :-)
it's moving up :-)
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.